News

Scientists at Quris Technologies have uncovered evidence that some drugs become significantly more harmful to brain ...
Scientists have discovered a new immunotherapy strategy that reduces cancer recurrence in mouse experimental models. The study, published in Nature Communications, shows that a specific subtype of ...
Animal testing requirements for monoclonal antibodies and other medications will be “reduced, refined or potentially replaced ...
A vaccine under development has demonstrated complete protection in mice against a deadly variant of the virus that causes bird flu. The work focuses on the H5N1 variant known as 2.3.4.4b, which has ...
Researchers reveal that the guinea pig pre-implantation embryo is very similar to the human embryo, spurring a better understanding of infertility and early human development.
NU-9 targets a shared underlying mechanism found in various neurodegenerative diseases. A new study from Northwestern ...
Analysts at William Blair expect drug developers will continue to perform “at least some animal testing” on their ...
Animal testing will be "reduced, refined or potentially replaced" by a suite of new approach methodologies (NAMs), including computational models and human cell lines and organoids, the agency ...
VivoSim Labs, Inc. (Nasdaq: VIVS) (the 'Company”) announced that it has emerged from stealth mode to dramatically impact drug discovery and development.
The agency said in a release that its animal testing requirements would be “reduced, refined, or potentially replaced using a ...
Three-dimensional models allow researchers to better represent complex tissues and cell-cell interactions. This article explores the cell models currently used by researchers to understand disease and ...